Pegunigalsidase Alfa: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Pegunigalsidase Alfa. Educational only — not medical advice.
Labeled uses
ELFABRIO is indicated for the treatment of adults with confirmed Fabry disease.
Source: FDA labeling via NIH DailyMed (set 6fb674bf…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.